The Center for Cancer and Blood Disorders receives authorization to administer FDA-approved CAR T-cell therapy; begins treating first community oncology patient in Maryland-area clinic
Ralph V. Boccia, MD, FACP, Oncology and Hematology, The Center for Cancer and Blood Disorders; Shreya Desai, MD, Oncology and Hematology, The Center for Cancer and Blood Disorders; Susan M. Granato, CRNP, Nurse Practitioner, The Center for Cancer and Blood Disorders; Josiane A. Tossa, PA-C, MPH, Physician Assistant, The Center for Cancer and Blood Disorders; Katie Goodman, Vice President of Clinical Research, American Oncology Network
Format
PNG
Source
American Oncology Network